Last reviewed · How we verify
NCT04503239: T2Help
Prediabetes and Type 2 Diabetes Data Collection Study
trial testing G6 in Diabetes Mellitus, Type 2 in 306 participants. Status unknown.
27 February 2022
Quick facts
| Lead sponsor | DexCom, Inc. |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 306 |
| Start date | 22 July 2020 |
| Primary completion | 27 February 2022 |
| Estimated completion | 27 February 2022 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- G6
Conditions studied
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
- Pre-diabetes — all drugs for Pre-diabetes →
Sponsor
DexCom, Inc.
Who can join
18 and older, any sex, with Diabetes Mellitus, Type 2 or Pre-diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To collect data in an observational study from Prediabetes (PD) and Type 2 Diabetes (T2D) patients including time correlated CGM, medication and food intake approximately 80% of the time for each subject that completes the entire active phase.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04503239
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus, Type 2
Currently open trials in the same condition.
- NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
- NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
- NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
- NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
Other DexCom, Inc. trials
Trials by the same sponsor.
- NCT06483945 — Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) · recruiting
- NCT05746286 — Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia · NA · completed
- NCT04905628 — Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus · unknown
- NCT04794478 — Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System · NA · completed
- NCT04840446 — Evaluation of Modified Adhesives With Dexcom G6 Sensor · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04503239 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by DexCom, Inc.
- Last refreshed: 5 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04503239.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing